Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir in Chronic Lymphocytic Leukemia
NCT01255644Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2010
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valganciclovir in chronic lymphocytic leukemia (CLL), sponsored by Medical University of Vienna. Started Dec 2010; status: completed.
02
Drugs
valganciclovir
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01255644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255644.